Statistics for Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical trial
Total visits
| views | |
|---|---|
| Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical trial | 68 |
Total visits per month
| views | |
|---|---|
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal.pdf | 47 |
Top country views
| views | |
|---|---|
| United States | 38 |
| Chile | 13 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 13 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |